← Eichor
Condition: Lung Cancer Stage Ia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lung Cancer Stage Ia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NA · 1 location(s) · Shanghai Chest Hospital · NCT06503744Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
NA · 1 location(s) · Hangzhou Broncus Medical Co., Ltd. · NCT06052098Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Phase 1 · 18 location(s) · Duke Street Bio Ltd · NCT06458712A Study of JMT203 in Patients With Cancer Cachexia
Phase 1/Phase 2 · 1 location(s) · Shanghai JMT-Bio Inc. · NCT06868849Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
EARLY_Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07235280A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 · 3 location(s) · RasCal Therapeutics, Inc. · NCT04678648Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03819296Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT04631770
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.